HAEMONETICS CORP — Director's Dealing 2017

May 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-05-22

Reporting Person: MERRIMAN RONALD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-22	Common Stock	M	7118	$34.405	Acquired	24925	Direct
2017-05-22	Common Stock	S	7118	$40.3087	Disposed	17807	Direct
2017-05-22	Common Stock	M	10353	$30.5025	Acquired	28160	Direct
2017-05-22	Common Stock	S	10353	$40.3363	Disposed	17807	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-22	Non-qualified Stock Option (Right to Buy)	$34.405	M	7118	Disposed	2018-07-21	Common Stock (7118)	Direct
2017-05-22	Non-qualified Stock Option (Right to Buy)	$35.5025	M	10353	Disposed	2021-07-23	Common Stock (10353)	Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.